FDA Approves Eisai’s Halaven™ (Eribulin Mesylate) Injection For Treatment Of Metastatic Breast Cancer
Eisai Inc. announced today that the United States Food and Drug Administration (FDA) has approved Halaven™ (eribulin mesylate) Injection for the treatment of patients with metastatic breast cancer who have previously received at least two chemotherapeutic regimens for the treatment of metastatic disease. Prior therapy should have included two common chemotherapy treatments, an anthracycline and …
Read more on Medical News Today
FDA approves treatment of drug for aggressive breast cancer
The FDA approves Halaven for treatment of patients with metastatic breast cancer who have received at least two prior chemotherapy regimens for late-stage disease. Patients were randomly assigned to receive treatment with either Halaven or a different single agent therapy chosen by their oncologist.
Read more on WCBD-TV Charleston
Ex-prison guard granted treatment in drug case
LEBANON — A former state corrections officer was ordered to undergo drug treatment in lieu of a conviction today after she and another ex-officer were found inside a car with more than 100 pills and a note suggesting they were smuggling drugs to inmates.Warren County Common Pleas Judge Robert Peeler ordered Annika Skinner, 36, of Clearcreek Twp., to undergo the treatment and follow other …
Read more on Dayton Daily News